Vivos Therapeutics, Inc. Common Stock (NASDAQ: VVOS) last traded at $0.297, up 6.41% on the session. The quote above updates while this page is open; the figures below are drawn from Vivos Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Vivos Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker VVOS. Its market capitalisation is $5.98 million.
Valuation measures for Vivos Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.98M |
|---|---|
| Enterprise value | $32.33M |
| Price / sales | 0.29 |
| Beta | 1.03 |
Trailing-twelve-month figures tagged in Vivos Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $20.90M |
|---|---|
| Net income (TTM) | -$25.52M |
| Gross margin | 61.89% |
| Operating margin | -107.89% |
| Cash | $1.77M |
Range and volume for VVOS over the past 52 weeks.
| 52-week high | $5.12 |
|---|---|
| 52-week low | $0.260 |
| Volume | 110.0K |
| Average volume | 2.50M |
| Previous close | $0.279 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.